Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 7,104 | 4,496 | 4,160 | 3,603 | 4,839 |
| Cost of Goods | 1,512 | 869 | 769 | 684 | 954 |
| Gross Profit | 5,592 | 3,627 | 3,391 | 2,919 | 3,885 |
| Operating Expenses | 7,107 | 6,936 | 5,549 | 6,447 | 8,219 |
| Operating Income | -1,003 | -2,440 | -1,389 | -2,844 | -3,380 |
| Other Income | -2,034 | 67 | 2,748 | -1,965 | 1,266 |
| Pre-tax Income | -3,037 | -2,373 | 1,359 | -4,809 | -2,114 |
| Income Tax | N/A | -8 | 8 | N/A | 0 |
| Net Income Continuous | -3,037 | -2,365 | 1,351 | -4,809 | -2,114 |
| Net Income | $-3,037 | $-2,365 | $1,351 | $-4,809 | $-2,114 |
| EPS Basic Total Ops | 0.05 | -0.02 | 0.02 | -0.16 | 2.30 |
| EPS Basic Continuous Ops | 0.05 | -0.02 | 0.02 | -0.15 | 2.68 |
| EPS Diluted Total Ops | 0.07 | -0.02 | 0.00 | -0.16 | 7.23 |
| EPS Diluted Continuous Ops | 0.07 | -0.02 | 0.00 | -0.15 | 7.24 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.02 | 0.00 | N/A | N/A |
| EBITDA(a) | $-642 | $-2,146 | $-1,347 | $-2,785 | $-4,617 |